<DOC>
	<DOCNO>NCT02025842</DOCNO>
	<brief_summary>To evaluate impact liver fibrosis variable [ e.g. , age , sex , virological response ( VR ) , previous resistance nucleoside/nucleotide analogue ( NUC ) therapy ] Hepatocellular carcinoma incidence Italian population genotype D HBeAg-negative CHB patient treat long-term NUC therapy .</brief_summary>
	<brief_title>Hepatitis B Virus HBeAg-negative Genotype D Patients Hepatocellular Carcinoma</brief_title>
	<detailed_description>Hepatocellular carcinoma ( HCC ) usually develop patient chronic liver disease , particularly patient liver cirrhosis . Chronic hepatitis B ( CHB ) one frequent underlie cause HCC . Several study demonstrate variation hepatitis B virus ( HBV ) genotype different effect HCC . HBV genotypes C D low responses interferon-based therapy high frequency basal core promoter mutation genotypes A B.For reason , HBV genotypes C D seem lead severe liver disease , include cirrhosis , compare HBV genotype . Because liver cirrhosis one strong HCC risk factor CHB patient , antiviral therapy may prevent development liver complication HCC . The aim study evaluate impact liver fibrosis variable , age , sex , virological response ( VR ) , resistance nucleoside/nucleotide analogue ( NUC ) therapy , population genotype D HBeAg-negative CHB patient treat long-term NUC therapy .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>Only chronic hepatitis B compensate cirrhosis HBeAgnegative genotype D patient include study.The patient include study â‰¥18 year old receive treatment nucleoside/nucleotide period least 18 month . Patients Hepatocellular carcinoma diagnose first 18 month nucleoside/nucleotide therapy , well patient coinfected hepatitis D , hepatitis C , HIV , exclude . Patients decompensated cirrhosis exclude low number case observe .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Hepatocellular carcinoma</keyword>
	<keyword>Hepatitis B</keyword>
</DOC>